P180003/S014: BioMimics 3D Vascular Stent System
FDA’s recorded scope: changes to the stent surface finish inspection criteria on stents lengths from 60mm to 125 mm
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 2 FDA records to the applicant name Veryan Medical, Ltd.. 2 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Jan 7, 2026 to Feb 19, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code NIP appears in 2 of the 2 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P180003, with 2 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: Unit 15, City Business Centre, Brighton Rd., Horsham, RH13 5BB. Recorded on P180003/S014, decision dated Feb 19, 2026.
FDA’s recorded scope: changes to the stent surface finish inspection criteria on stents lengths from 60mm to 125 mm
FDA’s recorded scope: approval to change the supplier of the distal tip component of the Delivery System
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
BioMimics 3D Vascular Stent SystemP180003/S014 | Veryan Medical, Ltd. | PMA supplement | Feb 19, 2026 | FDA |
BioMimics 3D Vascular Stent SystemP180003/S013 | Veryan Medical, Ltd. | PMA supplement | Jan 7, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.